Vault-13

Kynam Capital Management, LP

PRINCETON, NJ · CIK 1907884 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2022 · limited partnership

As an employer

$955.2m reported value +6.3% vs Q1 2024
22positions
87.6%in top 10
2 new 17 added 2 reduced 1 sold out vs Q1 2024

Options: 1 call positions ($67.0m notional), 3 put positions ($274.2m notional) – listed below, not included above.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 2,014,408 $218.1m22.84% 22.84% AddedShares held: Q3 2023 3.0m, Q4 2023 2.4m, Q1 2024 2.0m, Q2 2024 2.0m +14.4k +14,408 0.7%
2 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 3,388,967 $125.4m13.13% 13.13% AddedShares held: Q3 2023 3.2m, Q4 2023 3.0m, Q1 2024 2.9m, Q2 2024 3.4m +489.0k +488,967 16.9%
3 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 5,722,057 $117.5m12.30% 12.30% AddedShares held: Q3 2023 3.6m, Q4 2023 5.7m, Q1 2024 5.7m, Q2 2024 5.7m +62.1k +62,057 1.1%
4 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 7,082,562 $79.5m8.33% 8.33% AddedShares held: Q3 2023 500.0k, Q4 2023 1.5m, Q1 2024 4.2m, Q2 2024 7.1m +2.8m +2,842,782 67.0%
5 COGENT BIOSCIENCES INC COM COGT COGT 9,260,385 $78.1m8.17% 8.17% AddedShares held: Q3 2023 2.2m, Q4 2023 5.9m, Q1 2024 8.5m, Q2 2024 9.3m +760.4k +760,385 8.9%
6 VAXCYTE INC COM PCVX PCVX 753,240 $56.9m5.95% 5.95% AddedShares held: Q3 2023 1.3m, Q4 2023 1.0m, Q1 2024 745.0k, Q2 2024 753.2k +8.2k +8,240 1.1%
7 VERA THERAPEUTICS INC CL A VERA VERA 1,543,669 $55.8m5.85% 5.85% AddedShares held: Q3 2023 3.0m, Q4 2023 3.7m, Q1 2024 1.5m, Q2 2024 1.5m +16.9k +16,882 1.1%
8 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 8,826,710 $54.5m5.71% 5.71% AddedShares held: Q3 2023 3.1m, Q4 2023 4.6m, Q1 2024 6.5m, Q2 2024 8.8m +2.3m +2,299,219 35.2%
9 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 800,000 $27.7m2.90% 2.90% ReducedShares held: Q3 2023 1.8m, Q4 2023 2.0m, Q1 2024 1.1m, Q2 2024 800.0k -344.2k -344,242 -30.1%
10 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 5,953,825 $22.9m2.40% 2.40% UnchangedShares held: Q3 2023 6.0m, Q4 2023 6.0m, Q1 2024 6.0m, Q2 2024 6.0m
11 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,750,000 $22.8m2.38% 2.38% AddedShares held: Q3 2023 699.7k, Q4 2023 607.9k, Q1 2024 133.9k, Q2 2024 1.8m +1.6m +1,616,123 1207.2%
12 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 3,975,521 $19.8m2.08% 2.08% AddedShares held: Q3 2023 3.9m, Q4 2023 3.9m, Q1 2024 3.9m, Q2 2024 4.0m +43.4k +43,439 1.1%
13 TRAVERE THERAPEUTICS INC COM TVTX TVTX 2,021,659 $16.6m1.74% 1.74% AddedShares held: Q3 2023 957.5k, Q4 2023 2.0m, Q1 2024 2.0m, Q2 2024 2.0m +21.7k +21,659 1.1%
14 LIQUIDIA CORPORATION COM NEW LQDA LQDA 916,574 $11.0m1.15% 1.15% ReducedShares held: Q3 2023 2.0m, Q4 2023 2.7m, Q1 2024 2.2m, Q2 2024 916.6k -1.3m -1,331,750 -59.2%
15 IRONWOOD PHARMACEUTICALS INC COM CL A IRWD IRWD 1,641,891 $10.7m1.12% 1.12% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.6m, Q2 2024 1.6m +16.9k +16,891 1.0%
16 TYRA BIOSCIENCES INC COM TYRA TYRA 566,715 $9.1m0.95% 0.95% AddedShares held: Q3 2023 0, Q4 2023 340.2k, Q1 2024 515.2k, Q2 2024 566.7k +51.5k +51,525 10.0%
17 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 12,155,830 $8.4m0.88% 0.88% AddedShares held: Q3 2023 12.0m, Q4 2023 12.0m, Q1 2024 12.0m, Q2 2024 12.2m +132.9k +132,873 1.1%
18 BURNING ROCK BIOTECH LTD SPONSORED ADS BNR BNR 974,668 $6.3m0.66% 0.66% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 974.7k
19 SUTRO BIOPHARMA INC COM COM 2,023,683 $5.9m0.62% 0.62% AddedShares held: Q3 2023 1.6m, Q4 2023 2.0m, Q1 2024 2.0m, Q2 2024 2.0m +22.0k +21,956 1.1%
20 ACELYRIN INC COM COM 831,310 $3.7m0.38% 0.38% AddedShares held: Q3 2023 1.2m, Q4 2023 1.2m, Q1 2024 396.4k, Q2 2024 831.3k +434.9k +434,931 109.7%
21 CARIBOU BIOSCIENCES INC COM CRBU CRBU 1,646,702 $2.7m0.28% 0.28% AddedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.6m +578.2k +578,175 54.1%
22 CG ONCOLOGY INC COM CGON CGON 53,911 $1.7m0.18% 0.18% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 53.9k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
BURNING ROCK BIOTECH LTD 9,640,914 $7.0m9.6m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
VERTEX PHARMACEUTICALS INC VRTX · Put VRTXPut 330,000 $154.7m330.0k shares Added
SPDR S&P 500 ETF TR SPY · Put SPYPut 200,000 $109.1m200.0k shares New
INSMED INC INSM · Call INSMCall 1,000,000 $67.0m1.0m shares New
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 43,000 $10.4m43.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
BURNING ROCK BIOTECH LTD 13G · filed 2026-05-15 14.0% +3.0 pts 13G 2026-05-15
SYNDAX PHARMACEUTICALS INC SNDX · 13G · filed 2025-02-14 SNDX 10.0%≈ $186.2m 13G 2025-02-14
CYTOMX THERAPEUTICS INC CTMX · 13G · filed 2026-08-14 CTMX 10.0% +3.1 pts 13G 2026-08-14
CELLDEX THERAPEUTICS INC NEW CLDX · 13G · filed 2026-08-14 CLDX 6.8% -2.0 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 5.7% +4.2 pts 13G 2026-08-14
SUTRO BIOPHARMA INC 13G · filed 2026-05-15 5.3% -1.2 pts 13G 2026-05-15
CULLINAN THERAPEUTICS INC CGEM · 13G · filed 2026-03-04 CGEM 5.3%≈ $56.7m new 13G 2026-03-04